The Green Organic Dutchman Announces Changes to Senior Sales Team Following Galaxie Acquisition

3.4 min readPublished On: December 10th, 2021By

TORONTO – The Green Organic Dutchman Holdings Ltd. (CSE: TGOD) (US-OTC: TGODF), a global cannabis company announced changes to its senior sales team to drive forward sales strategies and accelerate the launch of the Company’s innovative products throughout Canada following the Galaxie Brands Corporation acquisition.

Rachel D’Silva is joining the TGOD management team as VP Sales – Galaxie, and will be managing Key accounts for TGOD in addition to managing the Cruuzy sales growth. Rachel has been Vice President Sales at recently acquired Galaxie Brands Corporation since March 2021. Ms. D’Silva has extensive experience in the cannabis and alcohol industries. She previously was Chief Sales Officer at Fluent Beverages, a cannabis beverage JV between Labatt Breweries and Tilray and held senior marketing roles at Aphria, Diageo and InBev.

Robert Gora, Vice President Sales-TGOD, will continue to lead the independent retail and medical channels, as well as the dedicated sales force represented through Acosta across the country. Prior to joining TGOD in 2019, Mr. Gora was General Manager, Medical for MedReleaf and has more than fifteen years experience in the pharma industry, having worked for Innomar Strategies and Brystol-Myers Squibb.

“As we continue to develop strategies to support and increase sales, address commercial gaps and respond to rapidly changing market conditions, we will leverage Robert’s and Rachel’s experience in the cannabis industry to execute sales strategies that drive sell-through,” said Sean Bovingdon, TGOD’s CEO and Interim CFO.

The Company further announces the departure of Gayle Duncan, CGO effective December 15th, 2021. The Company appreciates Gayle’s contribution in establishing The Green Organic Dutchman as an emerging leader in quality and sustainable cannabis.

Cautionary Statements

This news release includes statements containing certain “forwardlooking information” within the meaning of applicable securities law (“forwardlooking statements”). Forward looking statements in this release include, but are not limited to, statements about future revenue, statements about potential sales, statements about the offering of any particular products by the Company in any jurisdiction and statements regarding the future performance of the Company, statements about future development and delivery of products, and statements about the level of demand for TGOD’s and Galaxie’s products. Forwardlooking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “should”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forwardlooking statements throughout this news release. Forwardlooking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties (including market conditions) and other factors that could cause actual events or results to differ materially from those projected in the forwardlooking statements, including those risk factors described in the Company’s most recent Annual Information Form filed with Canadian securities regulators and available on the Company’s issuer profile on SEDAR at Although the Company believes that the assumptions and factors used in preparing the forward-looking information or forward-looking statements in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information and forward-looking statements included in this news release are made as of the date of this news release. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forwardlooking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither the CSE nor the CSE’s Regulation Services Provider (as that term is defined in the policies of CSE) accept responsibility for the adequacy or accuracy of this release.

(This information is primarily sourced from he Green Organic Dutchman Holdings Ltd.  Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).

About the Author: News Team

Newsteam at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Share This Story, Choose Your Platform!

Latest News

  • Medical Marijuana Market

Global Medical Marijuana Market Report 2022-2030

October 3rd, 2022|

Dublin - The global medical marijuana market size is expected to reach USD 65.8 billion by 2030 and is expected to expand at a CAGR of 21.6% The major factors attributed to the industry growth ...